[
    [
        {
            "time": "",
            "original_text": "30家药企2020年上半年业绩出炉：净利润最高增长14倍、最大降幅达165%",
            "features": {
                "keywords": [
                    "药企",
                    "2020年上半年",
                    "业绩",
                    "净利润",
                    "增长",
                    "降幅"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "mixed",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "30家药企2020年上半年业绩出炉：净利润最高增长14倍、最大降幅达165%",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "解密主力资金出逃股连续5日净流出573股",
            "features": {
                "keywords": [
                    "主力资金",
                    "出逃",
                    "净流出",
                    "573股"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "解密主力资金出逃股连续5日净流出573股",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "新冠疫苗成本定价，半年报发布，康希诺市值缩水77亿 连续下跌",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "成本定价",
                    "半年报",
                    "康希诺",
                    "市值缩水",
                    "连续下跌"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "新冠疫苗成本定价，半年报发布，康希诺市值缩水77亿 连续下跌",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药生物指数大幅跑赢市场多重因素驱动行业格局和企业估值重塑",
            "features": {
                "keywords": [
                    "医药生物",
                    "指数",
                    "跑赢市场",
                    "多重因素",
                    "行业格局",
                    "企业估值",
                    "重塑"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物指数大幅跑赢市场多重因素驱动行业格局和企业估值重塑",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "业绩来了！新冠疫苗第一股却盘中大跌13% 盈利能力下降",
            "features": {
                "keywords": [
                    "业绩",
                    "新冠疫苗",
                    "第一股",
                    "盘中大跌",
                    "盈利能力",
                    "下降"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "业绩来了！新冠疫苗第一股却盘中大跌13% 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]